These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28904327)

  • 1. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017.
    Song P; Cai Y; Tang H; Li C; Huang J
    Biosci Trends; 2017; 11(4):389-398. PubMed ID: 28904327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update.
    Wen N; Cai Y; Li F; Ye H; Tang W; Song P; Cheng N
    Biosci Trends; 2022 Mar; 16(1):20-30. PubMed ID: 35197399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016.
    Yu SJ
    Clin Mol Hepatol; 2016 Mar; 22(1):7-17. PubMed ID: 27044761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.
    Fong ZV; Tanabe KK
    Cancer; 2014 Sep; 120(18):2824-38. PubMed ID: 24897995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review.
    Seth I; Siu A; Hewitt L; Budak U; Farah B; Jaber M
    J Gastrointest Cancer; 2024 Mar; 55(1):318-331. PubMed ID: 37480425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
    Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
    Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
    Yamakado K; Kudo M
    Oncology; 2014; 87 Suppl 1():78-81. PubMed ID: 25427737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice.
    Zhao C; Nguyen MH
    J Clin Gastroenterol; 2016 Feb; 50(2):120-33. PubMed ID: 26583266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
    Cheng S; Chen M; Cai J;
    Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA; Welling T
    Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011.
    Song P; Tobe RG; Inagaki Y; Kokudo N; Hasegawa K; Sugawara Y; Tang W
    Liver Int; 2012 Aug; 32(7):1053-63. PubMed ID: 22432445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
    Kudo M; Okanoue T;
    Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].
    Ikai I
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):343-8. PubMed ID: 19068716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
    Omata M; Cheng AL; Kokudo N; Kudo M; Lee JM; Jia J; Tateishi R; Han KH; Chawla YK; Shiina S; Jafri W; Payawal DA; Ohki T; Ogasawara S; Chen PJ; Lesmana CRA; Lesmana LA; Gani RA; Obi S; Dokmeci AK; Sarin SK
    Hepatol Int; 2017 Jul; 11(4):317-370. PubMed ID: 28620797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study.
    Borzio M; Fornari F; De Sio I; Andriulli A; Terracciano F; Parisi G; Francica G; Salvagnini M; Marignani M; Salmi A; Farinati F; Carella A; Pedicino C; Dionigi E; Fanigliulo L; Cazzaniga M; Ginanni B; Sacco R;
    Future Oncol; 2013 Feb; 9(2):283-94. PubMed ID: 23414477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan.
    Song P; Tang W; Hasegawa K; Kokudo N
    Drug Discov Ther; 2014 Apr; 8(2):64-70. PubMed ID: 24815580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current global development of screening guidelines for hepatocellular carcinoma: a systematic review].
    Yang JC; Yu SQ; Gao L; Zhou QX; Zhan SY; Sun F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1126-1137. PubMed ID: 32741183
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.